Streetbeat News

Equity Actions

CME

CME Group has announced the extension of Chairman and CEO Terry Duffy's employment agreement through December 31, 2025. The Board, recognizing Duffy's leadership and expertise, believes his continued role is in the best interest of the company and its shareholders. Duffy, with over 40 years in the futures industry, has been in his current position since 2016 and has held various leadership roles within CME Group since 2002.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 11:07 pm

NOC

Northrop Grumman announced a new share repurchase authorization of $2.5 billion, raising the total authorized amount for buybacks to $3.8 billion.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 10:59 pm

UBX

Unity Biotechnology has announced a secondary offering of up to $2.27 million shares of common stock, according to a recent filing.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 10:32 pm

RCAT

Red Cat Holdings plans to sell common shares in a public offering, with terms yet to be disclosed. The company will also give the underwriter a 45-day option to buy up to an additional 15% of the shares to cover over-allotments. Proceeds will be used for general corporate purposes, working capital, and capital expenditures.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 10:18 pm

DRUG

Bright Minds Biosciences has announced a fully management-subscribed private placement of up to 661,765 units at $1.36 per unit, targeting gross proceeds of up to $900,000.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 10:11 pm

PHUN

Phunware, Inc. has announced a public offering to sell shares of its common stock, or pre-funded warrants as an alternative. This move is aimed at raising capital, although the specific terms and the amount of funds intended to be raised have not been disclosed. The offering's success and the market's reception will influence the short-term performance of Phunware's stock.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:51 pm

WVE

Wave Life Sciences' stock is trading lower following the announcement of a proposed public offering of ordinary shares and pre-funded warrants. This move typically dilutes existing shareholders and can put downward pressure on the stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:48 pm

CNM

Core & Main has announced an underwritten secondary public offering of 15 million shares by selling shareholders. Concurrently, the company plans to repurchase and redeem 3.13 million shares and 1.87 million partnership interests of Core & Main Holdings, LP.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:45 pm

ETNB

89bio, Inc. has announced its intention to conduct a public offering of common stock and pre-funded warrants. The company has commenced an underwritten offering aiming to raise $125 million through the sale of shares. Additionally, 89bio is expected to provide underwriters a 30-day option to purchase up to an additional $18.75 million of its common stock at the public offering price.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:45 pm

NKLA

Nikola Corporation's stock price is trading lower following the announcement of proposed offerings of common stock and convertible senior notes, which could dilute existing shareholders and increase the company's debt.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 9:45 pm